These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11097594)

  • 41. Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography.
    Shousha MA; Karp CL; Perez VL; Hoffmann R; Ventura R; Chang V; Dubovy SR; Wang J
    Ophthalmology; 2011 Aug; 118(8):1531-7. PubMed ID: 21507486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.
    Papandroudis AA; Dimitrakos SA; Stangos NT
    Cornea; 2002 Oct; 21(7):715-7. PubMed ID: 12352093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of mitomycin C for corneal-conjunctival intraepithelial neoplasia: management options--case reports].
    de Figueirêdo RS; de Figueirêdo ES
    Arq Bras Oftalmol; 2006; 69(3):407-11. PubMed ID: 16936968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil.
    Midena E; Angeli CD; Valenti M; de Belvis V; Boccato P
    Br J Ophthalmol; 2000 Mar; 84(3):268-72. PubMed ID: 10684836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent intraepithelial neoplasia treatment.
    Schechter BA; Nagler RS; Schrier A
    Ophthalmology; 2005 Jul; 112(7):1319; author reply 1319. PubMed ID: 15993243
    [No Abstract]   [Full Text] [Related]  

  • 49. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C.
    Heigle TJ; Stulting RD; Palay DA
    Am J Ophthalmol; 1997 Sep; 124(3):397-9. PubMed ID: 9439368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitomycin C therapy for corneal intraepithelial neoplasia.
    Frucht-Pery J; Rozenman Y
    Am J Ophthalmol; 1994 Feb; 117(2):164-8. PubMed ID: 8116744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Topical interferon alfa-2b for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
    Pérez de Arcelus M; Aranguren M; Andonegui J
    An Sist Sanit Navar; 2012; 35(1):137-41. PubMed ID: 22552136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
    Rodríguez-Pérez C; Del Campo Z; Wolley-Dod C; Gris O
    Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
    Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
    Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia.
    Huerva V; Sánchez MC; Mangues I
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):143-5. PubMed ID: 17444802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.
    Pérez-García P; Burgos-Blasco B; Gómez-Calleja V; Vidal-Villegas B; Méndez-Fernández R; Gegúndez-Fernández JA; Díaz-Valle D
    J Oncol Pharm Pract; 2023 Jun; 29(4):975-979. PubMed ID: 36131486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Gebhardt DO
    Am J Ophthalmol; 1998 Mar; 125(3):416-7. PubMed ID: 9512172
    [No Abstract]   [Full Text] [Related]  

  • 60. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.